Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017)
30.36
-0.10 (-0.33%)
Nov 5, 2026, 3:13 PM AST
TADAWUL:4017 Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, TADAWUL:4017 stock has a consensus rating of "Hold" and an average price target of SAR 36.98. The average 1-year stock price forecast is 21.81% higher than the current stock price, while the lowest is SAR 33.00 (+8.70%) and the highest is SAR 40.00 (+31.75%).
Price Target: SAR 36.98 (+21.81%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for TADAWUL:4017 stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 5 | 5 | 4 | 4 |
Financial Forecast
Revenue This Year
3.75B
from 3.09B
Increased by 21.23%
Revenue Next Year
4.40B
from 3.75B
Increased by 17.31%
EPS This Year
1.25
from 1.26
Decreased by -0.99%
EPS Next Year
1.33
from 1.25
Increased by 6.32%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.